It participants the metabolism of arachidonic acid by catalyzing oxaloacetic acid (OAA) to produce prostaglandin E2 (PGE2), which stimulates the production of leptin through EP3, thus promoting adipogenesis and inhibiting lipolysis to promote obesity (Jaworski et al., 2009). This evidence concerns the gene LEP and obesity disorder.